Aledade Appoints Dr. Lalith Vadlamannati as Chief Technology Officer
July 16, 2025 - 00:46
In a significant move for the organization, Aledade has officially announced the appointment of Dr. Lalith Vadlamannati as its new Chief Technology Officer. Dr. Vadlamannati brings a wealth of experience and expertise to the role, having previously held various leadership positions in technology and healthcare innovation.
As Aledade continues to expand its network of independent primary care practices, Dr. Vadlamannati's role will be crucial in advancing the company's technological initiatives. His background in data analytics and software development is expected to enhance Aledade's capabilities in delivering high-quality care and improving patient outcomes.
The company emphasizes its commitment to leveraging technology to empower primary care providers, making healthcare more accessible and efficient. Dr. Vadlamannati's vision aligns with Aledade's mission to support independent practices in navigating the complexities of the healthcare landscape. His leadership is anticipated to drive innovative solutions that will benefit both providers and patients alike.
MORE NEWS
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...